Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer (Q39356134)

11 September 2017

title

Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer (English)

1 reference

11 September 2017

1 reference

1 reference

Y Fukuma

1 reference

11 September 2017

H Matsui

1 reference

11 September 2017

H Koike

1 reference

11 September 2017

Y Sekine

1 reference

11 September 2017

I Shechter

1 reference

11 September 2017

N Ohtake

1 reference

11 September 2017

S Nakata

1 reference

11 September 2017

K Ito

1 reference

11 September 2017

K Suzuki

1 reference

11 September 2017

publication date

1 May 2012

1 reference

Prostate Cancer and Prostatic Diseases

11 September 2017

published in

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

339-345

1 reference

11 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Comparison of time trends in prostate cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Genomewide linkage analysis of familial prostate cancer in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Enzymes of the mevalonate pathway of isoprenoid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Molecular Cloning and Functional Analysis of the Promoter of the Human Squalene Synthase Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Multiple sequence elements are involved in the transcriptional regulation of the human squalene synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Differential transcriptional regulation of the human squalene synthase gene by sterol regulatory element-binding proteins (SREBP) 1a and 2 and involvement of 5' DNA sequence elements in the regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

K45R variant of squalene synthase increases total cholesterol levels in two study samples from a French Canadian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Structure and regulation of mammalian squalene synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

An update of the Gleason grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Coordinate regulation of lipogenic gene expression by androgens: Evidence for a cascade mechanism involving sterol regulatory element binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Androgens, lipogenesis and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Targeting the mevalonate pathway for improved anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Farnesyl pyrophosphate synthase modulators: a patent review (2006 - 2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Statin drugs and risk of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Familial prostate cancer in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D 3 Induced Cell Growth Inhibition in Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Urinary cholesterol. V. Its excretion in men with testicular and prostatic neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

New role for an established drug? Bisphosphonates as potential anticancer agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.14

31 March 2020

Identifiers

DOI

10.1038/PCAN.2012.14

1 reference

11 September 2017

1 reference